Welcome to the virtual newsroom for Aptimmune’s Launch of Barricade. Founded in 2010 by Dr. Federico Zuckermann, Aptimmune Biologics has meshed together some of the best in class technologies into a product able to deliver revolutionary results to producers. Barricade is the latest in vaccine formulation technology brought to producers exclusively by Aptimmune. Launched as an autogenous product, the intranasal mucosal inactivated vaccine for PRRS, brings together the best concepts in vaccine delivery and methodology people can use.
This virtual newsroom includes links to photos and audio from the event. All content posted here is available free of charge for digital or print publication or broadcast. Credit can be given to AgNewsWire.Interview with Dr. Gabriela Calzada-Nova, Aptimmune